Absence of vascular dementia in an autopsy series from a dementia clinic

Journal of the American Geriatrics Society

Volumn 46, Issue 5, 1998, Pages 597-604

  Nolan, Karen A ^a,b   Lino, M Maddelena ^a,c   Seligmann, Arthur W ^a   Blass, John P ^a,d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CATHOLIC UNIVERSITY   (Italy)

^d BURKE MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; NERVE DEGENERATION;

EID: 0031861864     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1998.tb01076.x     Document Type: Article

References (55)

1. Cummings JL, Benson DF. Dementia. A Clinical Approach. Boston: Butterworth-Heinemann, 1989.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Revised, 3rd Ed. Washington, DC: American Psychiatric Association, 1987.
3. Chui HC. Dementia. A review emphasizing clinicopathologic correlation and brain-behavior relationships. Arch Neurol 1989;46:806-814.
4. Drachman DA. New criteria for the diagnosis of vascular dementia: Do we know enough yet? Neurology 1993;43:243-245.
5. Chui HC, Victoroff JI, Margolin D et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992;42:473-480.
6. Wallin A, Blennow K. The clinical diagnosis of vascular dementia. Dementia 1994;5:181-184.
7. Gorelick PB, Mangone CA. Vascular dementias in the elderly. Clin Geriatr Med 1991;7:599-615.
8. Bendixen B. Vascular dementia: A concept in flux. Curr Opin Neurol Neurosurg 1993;6:107-112.
9. Hachinski V. Vascular dementia: A radical redefinition. Dementia 1994;5:130-132.
10. Roman GC, Tatemichi TK, Erkinjuntti T et al. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
11. Wetterling T, Kanitz RD, Borgis KJ. The ICD-10 criteria for vascular dementia. Dementia 1994;5:185-188.
12. Nussbaum M, Treves TA, Korczyn AD. DSM-III-R criteria for primary degenerative dementia and multi-infarct dementia. Alzheimer Dis Assoc Disord 1992;6:111-118.
13. Erkinjuntti T. Clinical criteria for vascular dementia: The NINDS-AIREN criteria. Dementia 1994;5:189-192.
14. Lopez OL, Larumbe MR, Becker JT et al. Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementia. Neurology 1994;44:1240-1245.
15. Reding MJ, Haycox J, Wigforss K et al. Follow up of patients referred to a dementia service. J Am Geriatr Soc 1984;32:265-268.
16. McKhann G, Drachman D, Folstein M et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
17. Hachinski VC, Iliff LD, Zilkha E et al. Cerebral blood flow in dementia. Arch Neurol 1975;36:632-637.
18. Rosen WG, Terry RD, Fuld PA et al. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486-488.
19. Loeb C, Gandolfo C. Diagnostic evaluation of degenerative and vascular dementia. Stroke 1983;14:399-401.
20. Liston EH, La Rue A. Clinical differentiation of primary degenerative and multi-inrarct dementia: A critical review of the evidence. Parr I. Clinical Studies. Biol Psychiatry 1983;18:1451-1465.
21. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
22. Joachim CL, Morris JH, Selkoe DJ. Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases. Ann Neurol 1988;24:50-56.
23. Morris JC, McKeel Jr. DW, Storandt M et al. Very mild Alzheimer's disease: Informanr-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 1991;41:469-478.
24. Galasko D, Hansen LA, Katzman R et al. Clinical-neuroparhological correlations in Alzheimer's disease and related dementias. Arch Neurol 1994;51:888-895.
25. Hulette C, Nochlin D, McKeel D et al. Neuropathologic basis of vascular dementia related to cerebral infarction. Neurology 1996;46:A364.
26. Black RS, Barclay LL, Nolan KA et al. Pentoxifylline in cerebrovascular dementia. J Am Geriatr Soc 1992;40:237-244.
27. Tatemichi TK, Desmond DW, Paik M et al. Clinical determinants of dementia related to stroke. Ann Neurol 1993;33:568-575.
28. Millikan CH, McDowell FH, Easron JD. Stroke. Philadelphia: Lea & Febiger, 1987.
29. Gilleard CJ, Kellert JM, Coles JA et al. The St. George's demenria bed investigation study: A comparison of clinical and pathological diagnosis. Acta Psychiatr Scand 1992;85:264-269.
30. Bucht G, Adolfsson R, Winblad B. Dementia of the Alzheimer type and multi-infarct dementia: A clinical description and diagnostic problems. J Am Geriatr Soc 1984;32:491-498.
31. Frisoni GB, Calabresi L, Geroldi C et al. Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular demenria. Dementia 1994;5:240-242.
32. Betard C, Robitaille Y, Gee M et al. Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular demenria. Neuroreport 1994;5:1893-1896.
33. Olichney JM, Hansen LA, Hofstetter CR et al. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 1995;52:702-708.
34. Thomas T, Thomas G, McLendon C et al. Bera-amyloid-mediared vasoacrivity and vascular endothelial damage. Nature 1996;380:168-171.
35. Buee L, Hof PR, Bouras C et al. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol (Berlin) 1994;87:469-480.
36. Harik SI. Changes in the glucose transporter of brain capillaries. Can J Physiol Pharmacol 1992;70 (suppl):S113-117.
37. Aronson MK, Ooi WL, Morgenstern H et al. Women, myocardial infarction, and dementia in the very old. Neurology 1990;40:1102-1106.
38. Sparks DL, Liu H, Scheff SW et al. Temporal sequence of plaque formation in the cerebral cortex of non-demented individuals. J Neuropathol Exp Neurol 1993;52:135-142.
39. Martins C, Gambert SR, Gupta KL et al. Effect of age and dementia on the presence of cardiovascular disease. Age 1990;13:9-11.
40. Sparks DL, Hunsaker III JC, Scheff SW et al. Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging 1990;11:601-607.
41. Sparks DL, Scheff SW, Hunsaker JC III et al. Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbirs with dietary cholesterol. Exp Neurol 1994;126:88-94.
42. Reiman EM, Caselli RJ, Yun LS et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 1996;334:752-758.
43. Small GW, Mazziotta JC, Collins MT et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 1995;273:942-947.
44. Kennedy AM, Frackowiak RS, Newman SK et al. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci Lett 1995;186:17-20.
45. Blass JP. Pathophysiology of the Alzheimer syndrome. Neurology 1993;43:S25-38.
46. Blass JP. Cerebral metabolic impairments. In: Khacharurian ZS, Rhadebaugh T, eds. Alzheimer's Disease. Miami: CRC Press, 1997.
47. Mutisya EM, Bowling AC, Beal MF. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J Neurochem 1994;63:2179-2184.
48. Harmon D. Free radical theory of aging: Alzheimer's disease parhogenesis. Age 1995;18:97-119.
49. Mattson MP. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor prorein mismetabolism, free radicals, and metabolic compromise. Ann N Y Acad Sci 1994;747:50-76.
50. Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1995;38:357-366.
51. Schulz JB, Beal MF. Neuroprotective effects of free radical scavengers and energy repletion in animal models of neurodegenerative disease. Ann N Y Acad Sci 1995;765:100-110; discussion 116-118.
52. Lechner H, Niederkorn K, Schmidt R. Does cerebrovascular insufficiency contribute to Alzheimer's disease? Ann NY Acad Sci. 1991;640:74-79.
53. Bick K, Amaducci L, Pepeu G. The early story of Alzheimer's disease. Padua: Lavinia Press, 1987.
54. Blass JP, Hoyer S, Nitsch R. A translation of Otto Binswanger's article, 'The delineation of the generalized progressive paralyses.' 1894. Arch Neurol 1991;48:961-972.
55. Blass JP, Hoyer S, Nitsch R. In reply. Arch Neurol. 1992;49:799-800.